Novosanis is a wholly owned subsidiary of OraSure Technologies Inc (NASDAQ: OSUR) and an innovative developer and producer of medical devices improving the quality of diagnostic tests as well as the accuracy of drug delivery for infectious diseases and oncology.
ISLB Congress Liquid biopsy - Postponed to October 30-31
Novosanis is excited to present a booth at ISLB, an international conference focusing on liquid biopsy. The congress takes place in Barcelona from 30 until 31 October. Our team is excited to share the potential of urine as a liquid biopsy, especially in the field of oncology, during a presentation...